In This Section

Newsroom

December 11, 2018
Temple-Led Research Team Traces Pathway to Cardioprotection in Post-Ischemic Heart Failure

A Temple-led research team shows for the first time that blocking GRK2 localization to mitochondria protects heart cells from ischemic injury and death, casting new light on GRK2 as a potential therapeutic target in post-injury heart failure.
- VIEW STORY
December 07, 2018
Major Gift Endows New Katz School of Medicine Chair

Temple named the first David Myers Professor and Chair in Otolaryngology-Head and Neck Surgery thanks to a generous gift from Eugene N. Myers, MED ’60, and his wife, Barbara.
- VIEW STORY
November 20, 2018
Temple Scientists Identify Novel Target for Neuron Regeneration and Functional Recovery in Spinal Cord Injury

The discovery of proteins that serve a central role in neuron regeneration is key to the development of drug therapies that have the potential to help patients regain function in their limbs after spinal cord injury.
- VIEW STORY
November 14, 2018
Dr. Lisa Rae Appointed Director of the Temple Burn Center

Lisa Rae, MD, FACS, has been appointed Director of the Temple Burn Center and Associate Professor of Surgery at the Lewis Katz School of Medicine at Temple University.
- VIEW STORY
November 06, 2018
Dr. William Auger Joins Temple as Chronic Thromboembolic Pulmonary Hypertension Specialist

William R. Auger, MD, has joined Temple University Hospital as a pulmonologist in the Pulmonary Hypertension, Right Heart Failure and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program in the Temple Heart and Vascular Institute, and Clinical Professor of Medicine at the Lewis Katz School of Medicine at Temple University.
- VIEW STORY
October 30, 2018
Lewis Katz School of Medicine at Temple University and Hunter College of the City University of New York Awarded $13.5 Million NCI/NIH Grant for Cancer Health Disparities

This joint grant, a first of its kind for any Pennsylvania or New Jersey institution, will examine cancer health inequity across multiple ethnic populations.
- VIEW STORY
October 25, 2018
New Epigenetic Drug Strategy to Treat Cancer

Researchers have discovered that inhibiting CDK9, a DNA transcription regulator, reactivates genes that have been epigenetically silenced by cancer.
- VIEW STORY
October 03, 2018
Temple Lung Center Director Reports Continued Positive Results for Study Examining Minimally Invasive Treatment of Severe Emphysema

Dr. Gerard Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, announced the 12-month results of the EMPROVE multicenter, randomized and controlled study for the Spiration® Valve System (SVS), a minimally invasive treatment for severe emphysema, at the European Respiratory Society International Congress (ERS) in Paris, France, on Sept. 18.
- VIEW STORY

Newsroom

Pages